Cancer Center Amsterdam
-
Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression
van Spronsen, M. F., Hanekamp, D., Westers, T. M., van Gils, N., Vermue, E., Rutten, A., Jansen, J. H., Lissenberg-Witte, B. I., Smit, L., Schuurhuis, G. J. & van de Loosdrecht, A. A., Mar 2023, In: Leukemia. 37, 3, p. 680-690 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
AML/normal progenitor balance instead of total tumor load (MRD) accounts for prognostic impact of flowcytometric residual disease in AML
Hanekamp, D., Tettero, J. M., Ossenkoppele, G. J., Kelder, A., Cloos, J. & Schuurhuis, G. J., 1 Jun 2021, In: Cancers. 13, 11, 2597.Research output: Contribution to journal › Article › Academic › peer-review
-
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting
Hanekamp, D., Snel, A. N., Kelder, A., Scholten, W. J., Khan, N., Metzner, M., Irno-Consalvo, M., Sugita, M., de Jong, A., Oude Alink, S., Eidhof, H., Wilhelm, M., Feuring-Buske, M., Slomp, J., van der Velden, V. H. J., Sonneveld, E., Guzman, M., Roboz, G. J., Buccisano, F., Vyas, P., & 5 others , 1 Sept 2020, In: British journal of haematology. 190, 6, p. 891-900 10 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications